Published in Arerugi on March 01, 1967
EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis (2005) 4.17
Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol (2013) 3.55
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child (2002) 2.11
Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med (1999) 1.98
Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia. Circulation (2012) 1.82
Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest (1986) 1.81
Kawasaki disease in Canterbury. Arch Dis Child (1978) 1.70
Advances in Kawasaki disease. Eur J Pediatr (2004) 1.66
Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response. Circ Cardiovasc Genet (2012) 1.65
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr (2006) 1.61
Clinical uses of intravenous immunoglobulin. Clin Exp Immunol (2005) 1.61
A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58
Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med (1993) 1.51
Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol (2009) 1.46
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One (2012) 1.45
Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immun (1993) 1.42
Kawasaki disease in Australia, 1993-95. Arch Dis Child (1998) 1.42
Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart (2000) 1.39
The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol (1989) 1.36
Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child (1995) 1.34
Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease. Pediatr Cardiol (2005) 1.30
Kawasaki syndrome. Clin Microbiol Rev (1998) 1.28
Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat Rev Rheumatol (2014) 1.24
Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun (2005) 1.21
Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet (2010) 1.20
Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J (2002) 1.20
Pathogenesis of Kawasaki disease. Clin Exp Immunol (2011) 1.18
Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med (1995) 1.17
Kawasaki disease. Yonsei Med J (2006) 1.16
Antineutrophil cytoplasm antibodies in Kawasaki disease. Arch Dis Child (1989) 1.15
Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int (2010) 1.10
Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med (2011) 1.08
Mycoplasma pneumoniae infection in patients with Kawasaki disease. Korean J Pediatr (2011) 1.08
Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol (2005) 1.07
Diagnosis of incomplete Kawasaki disease. Korean J Pediatr (2012) 1.07
Toxic shock syndrome in Canada. Can Med Assoc J (1982) 1.06
Kawasaki syndrome. Br Med J (Clin Res Ed) (1984) 1.06
Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology (1999) 1.04
Renal scarring sequelae in childhood Kawasaki disease. Pediatr Nephrol (2006) 1.04
Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J (2011) 1.03
Visualization of coronary arteries in patients after childhood Kawasaki syndrome: value of multidetector CT and MR imaging in comparison to conventional coronary catheterization. Pediatr Radiol (2007) 1.03
Predicting factors for refractory kawasaki disease. Korean Circ J (2010) 1.02
Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a "protein homeostasis system". Yonsei Med J (2012) 1.01
Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One (2013) 0.99
Coronary artery fistulas. Neth Heart J (2002) 0.99
Sensorineural hearing loss in patients with Kawasaki disease. Korean J Pediatr (2015) 0.98
Genetic polymorphisms in Kawasaki disease. Acta Pharmacol Sin (2011) 0.98
Korean guidelines for the appropriate use of cardiac CT. Korean J Radiol (2015) 0.96
Polymorphism of angiotensin-1 converting enzyme gene and Kawasaki disease. Pediatr Cardiol (2004) 0.95
Extracardial Vasculopathy After Kawasaki Disease: A Long-Term Follow-up Study. J Am Heart Assoc (2016) 0.94
Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis. Br Med J (Clin Res Ed) (1985) 0.94
Kawasaki Disease: A Clinician's Update. Int J Pediatr (2013) 0.93
Cytopathogenic protein in filtrates from cultures of Propionibacterium acnes isolated from patients with Kawasaki disease. Br Med J (Clin Res Ed) (1987) 0.93
Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr (2017) 0.92
Kawasaki disease: echocardiographic features in 91 cases presenting in the United Kingdom. Arch Dis Child (1990) 0.92
Familial occurrence of Kawasaki syndrome in North America. Arch Pediatr Adolesc Med (2005) 0.92
Coronary artery aneurysms and myocardial infarction: adult sequelae of Kawasaki disease? Br Heart J (1988) 0.92
Delayed apoptosis of circulating neutrophils in Kawasaki disease. Clin Exp Immunol (2001) 0.92
Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease. Clin Exp Immunol (2009) 0.92
Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Exp Immunol (2007) 0.91
Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation. J Pediatr (2012) 0.91
Mucocutaneous lymph node syndrome (Kawasaki disease) in an adult. West J Med (1981) 0.91
Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease. J Korean Med Sci (2008) 0.90
High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease. Clin Rheumatol (2007) 0.90
Epidemiology of Kawasaki disease in infants 3 months of age and younger. Korean J Pediatr (2012) 0.90
Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease. Arch Dis Child (1991) 0.90
Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells. Clin Exp Immunol (1995) 0.90
Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis (2010) 0.89
Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan. J Epidemiol (2014) 0.89
Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease. Pediatr Rheumatol Online J (2011) 0.89
Recent advances in the understanding and management of kawasaki disease. Curr Infect Dis Rep (2010) 0.89
Infectious disease: Blowing in the wind. Nature (2012) 0.89
Acute pancreatitis with Kawasaki disease: analysis of cases with elevated serum amylase levels. Eur J Pediatr (2004) 0.89
Carotid intima-media thickness and pulse wave velocity after recovery from kawasaki disease. Korean Circ J (2009) 0.89
Evaluation of the Temporal Association between Kawasaki Disease and Viral Infections in South Korea. Korean Circ J (2014) 0.88
Outstanding circulation research by Japanese scientists. J Anesth (2011) 0.88
Serum sodium levels in patients with Kawasaki disease. Pediatr Cardiol (2005) 0.88
Pathogenic characterization of a cervical lymph node derived from a patient with Kawasaki disease. Int J Clin Exp Pathol (2012) 0.88
Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness. Pediatr Cardiol (2003) 0.88
Atipical Kawasaki disease with coronary aneurysm in infant. Ital J Pediatr (2011) 0.88
Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol (2001) 0.88
Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease. ScientificWorldJournal (2012) 0.88
Recent Advances in Kawasaki Disease. Yonsei Med J (2016) 0.88
The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin Exp Immunol (2007) 0.87
Antiendothelial cell antibodies can be cytotoxic to endothelial cells without cytokine pre-stimulation and correlate with ELISA antibody measurement in Kawasaki disease. Clin Exp Immunol (1994) 0.87
Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness. BMC Pediatr (2008) 0.87
Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. J Epidemiol (2015) 0.86
Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease. Pediatr Cardiol (2013) 0.86
The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease. Eur J Pediatr (2009) 0.86
Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese. Hum Genet (2013) 0.85
A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis. PLoS One (2014) 0.85
Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol (2015) 0.84
FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response. Pharmacogenet Genomics (2013) 0.84
Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease. Eur J Pediatr (2004) 0.84
Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population. Pediatr Cardiol (2012) 0.84
Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci (2005) 0.84
Polymorphisms of human leukocyte antigen genes in korean children with Kawasaki disease. Pediatr Cardiol (2007) 0.84
Understanding the pathogenesis of Kawasaki disease by network and pathway analysis. Comput Math Methods Med (2013) 0.84
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis (2005) 4.17
Serum lectin with known structure activates complement through the classical pathway. J Biol Chem (1987) 2.79
Essential role of the small GTPase Rac in disease resistance of rice. Proc Natl Acad Sci U S A (2001) 2.45
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun (1995) 2.42
Structural and functional characterization of inositol 1,4,5-trisphosphate receptor channel from mouse cerebellum. J Biol Chem (1991) 2.23
Isolation and characterization of an avian hepatic binding protein specific for N-acetylglucosamine-terminated glycoproteins. J Biol Chem (1977) 2.18
Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol (1996) 2.18
Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation (1989) 2.14
The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem (1998) 2.07
The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med (1978) 2.05
Isolation and characterization of a mannan-binding protein from rabbit liver. Biochem Biophys Res Commun (1978) 2.04
Airway management of a child with temporomandibular joint ankylosis following otitis media. Anaesthesia (2002) 2.01
Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet (1992) 1.97
Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The "Ad Hoc' Working Group. Hypertension (1997) 1.90
Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut (2004) 1.89
Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics (2001) 1.85
Isolation and characterization of a mannan-binding protein from human serum. J Biochem (1983) 1.83
Kawasaki disease in families. Pediatrics (1989) 1.83
Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins. J Biol Chem (1976) 1.73
Sli2 (Ypk1), a homologue of mammalian protein kinase SGK, is a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. Mol Cell Biol (2000) 1.72
Alteration of the structural properties of starch components by the lack of an isoform of starch branching enzyme in rice seeds. J Biol Chem (1993) 1.71
Genetic mapping with a thiamine-requiring auxotroph of Escherichia coli K-12 defective in thiamine phosphate pyrophosphorylase. J Bacteriol (1968) 1.66
A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. J Infect Dis (1988) 1.57
Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology (2001) 1.52
Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol (2008) 1.52
Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann Intern Med (1998) 1.51
A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J Biochem (1989) 1.50
The nucleotide sequence of cDNA for a Drosophila ribosomal protein with homology to rat ribosomal protein S26. Nucleic Acids Res (1989) 1.48
A craniocervical injury-induced syringomyelia caused by central canal dilation secondary to acquired tonsillar herniation. Case report. J Neurosurg (2001) 1.48
Role of interleukin-10 on hyporesponsiveness of endotoxin during surgery. Crit Care Med (2000) 1.47
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Identification, cDNA cloning, and gene expression of soluble starch synthase in rice (Oryza sativa L.) immature seeds. Plant Physiol (1993) 1.43
Dislocated intraocular lens fixation using intraocular cowhitch knot. Am J Ophthalmol (2001) 1.43
An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries. Immunogenetics (2000) 1.42
Variable Bcl-2 phenotype in benign and malignant lesions of urothelium. Cancer Lett (1998) 1.42
Lesion mimic mutants of rice with alterations in early signaling events of defense. Plant J (1999) 1.42
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet (1996) 1.41
Colonic ulceration caused by administration of loxoprofen sodium. Intern Med (1999) 1.40
Response to interferon-alpha 2a in patients with e antigen-negative chronic hepatitis B. J Clin Gastroenterol (1997) 1.40
Thiamine uptake in Escherichia coli. I. General properties of thiamine uptake system in Escherichia coli. Arch Biochem Biophys (1969) 1.39
Effect of low concentration of epinephrine on human platelet aggregation analyzed by particle counting method and confocal microscopy. J Lab Clin Med (1997) 1.39
A case of tachycardia-induced cardiomyopathy due to chronic ectopic atrial tachycardia. Clin Cardiol (1993) 1.39
Molecular cloning of cytidine monophospho-N-acetylneuraminic acid hydroxylase. Regulation of species- and tissue-specific expression of N-glycolylneuraminic acid. J Biol Chem (1995) 1.39
Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials (2001) 1.38
The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein. J Biol Chem (1990) 1.36
Relations among climbing fiber responses of nearby Purkinje Cells. J Neurophysiol (1972) 1.34
Genomic organization of 251 kDa acetyl-CoA carboxylase genes in Arabidopsis: tandem gene duplication has made two differentially expressed isozymes. Plant Cell Physiol (1995) 1.34
Update of the epidemiology of Kawasaki disease in Japan--from the results of 1993-94 nationwide survey. J Epidemiol (1996) 1.33
The structure of a neural specific carbohydrate epitope of horseradish peroxidase recognized by anti-horseradish peroxidase antiserum. J Biol Chem (1991) 1.31
HLA antigens in Kawasaki disease. Pediatrics (1978) 1.31
Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans. J Biol Chem (1998) 1.30
Post-load glucose measurements in oral glucose tolerance tests correlate well with 1,5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance. Clin Sci (Lond) (2001) 1.30
Perforated appendicitis causing thigh emphysema: a case report. J Orthop Surg (Hong Kong) (2005) 1.28
Isolation and characterization of a mannan-binding protein from rat liver. J Biol Chem (1981) 1.28
Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. J Pathol (2006) 1.28
Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr (1986) 1.26
Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86. Lancet (1986) 1.23
Role of free radicals in ischemic rat liver cell injury: prevention of damage by alpha-tocopherol administration. Surgery (1986) 1.22
Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man. Biochem J (1989) 1.20
Comparative aspects of some bacterial dehydrogenases and transhydrogenases. J Bacteriol (1966) 1.19
Expression of androgen receptor through androgen-converting enzymes is associated with biological aggressiveness in prostate cancer. J Clin Pathol (2007) 1.18
Starch branching enzymes from immature rice seeds. J Biochem (1992) 1.18
Measurement of the differential branching fraction and forward-backward asymmetry for B --> K(*)l+l-. Phys Rev Lett (2009) 1.17
Isolation and characterization of a mannan-binding protein from rabbit serum. Biochem Biophys Res Commun (1980) 1.17
Organization of the gene for batroxobin, a thrombin-like snake venom enzyme. Homology with the trypsin/kallikrein gene family. J Biol Chem (1988) 1.16
Molecular cloning and sequence analysis of cDNA encoding the macrophage lectin specific for galactose and N-acetylgalactosamine. J Biol Chem (1990) 1.16
Carbohydrate structure of glycopeptides isolated from an hepatic membrane-binding protein specific for asialoglycoproteins. J Biol Chem (1976) 1.15
Cell surface Lactobacillus plantarum LA 318 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) adheres to human colonic mucin. J Appl Microbiol (2008) 1.15
Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics (1995) 1.14
Cloning and functional expression of a novel glucuronyltransferase involved in the biosynthesis of the carbohydrate epitope HNK-1. Proc Natl Acad Sci U S A (1997) 1.14
cDNA sequence and expression of a phosphoenolpyruvate carboxylase gene from soybean. Plant Mol Biol (1992) 1.14
Thiamine regulatory mutants in Escherichia coli. J Biochem (1969) 1.13
Metastatic tumours of the mouth and jaws. A review of the Japanese literature. J Maxillofac Surg (1982) 1.13
Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med (1995) 1.13
Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype. Histopathology (2008) 1.12
Inhibition of cytokinesis by a lipid metabolite, psychosine. J Cell Biol (2000) 1.12
Lymphocyte subsets identified by monoclonal antibodies in healthy children. Pediatr Res (1986) 1.12
Endoscopic resection of small inflammatory fibroid polyp of the colon. Intern Med (2000) 1.12
Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg (1994) 1.10
Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics (1991) 1.10
Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53. Int J Cancer (1996) 1.10
Nationwide survey on Kawasaki disease in Japan. Pediatrics (1987) 1.09
Mannan-binding protein and conglutinin in bovine serum. J Biochem (1985) 1.09
Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity. Proc Natl Acad Sci U S A (1999) 1.09
Quantitative measurement of abdominal arterial blood flow using image-directed Doppler ultrasonography: superior mesenteric, splenic, and common hepatic arterial blood flow in normal adults. J Clin Ultrasound (1989) 1.08
Tenascin-C regulates proliferation and migration of cultured astrocytes in a scratch wound assay. Neuroscience (2005) 1.08
Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicol Appl Pharmacol (1998) 1.07
Isolation and characterization of two distinct mannan-binding proteins from rat serum. Arch Biochem Biophys (1988) 1.07
Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma (2001) 1.06
Precision measurement of charged pion and kaon differential cross sections in e+ e- annihilation at sqrt[s]=10.52 GeV. Phys Rev Lett (2013) 1.06
Short-term modulation of cerebellar Purkinje cell activity after spontaneous climbing fiber input. J Neurophysiol (1992) 1.05
Thiamine uptake in Escherichia coli. 3. Regulation of thiamine uptake in Escherichia coli. Arch Biochem Biophys (1971) 1.05
Purification and characterization of endogenous protein activator of human platelet proteasome. J Biochem (1993) 1.05
Expression cloning of a cDNA encoding a sulfotransferase involved in the biosynthesis of the HNK-1 carbohydrate epitope. J Biol Chem (1997) 1.04
Genetic analysis of Kawasaki syndrome. Am J Hum Genet (1986) 1.04
Prevalence of hip osteoarthritis and acetabular dysplasia in french and japanese adults. Rheumatology (Oxford) (2000) 1.04
Adenine nucleotide metabolism during hepatic ischemia and subsequent blood reflow periods and its relation to organ viability. Transplantation (1980) 1.03
Characterization of human serum mannan-binding protein promoter. J Biochem (1999) 1.03